| |
|
|
|
Aeglea BioTherapeutics Inc.  
|
|
6.48 0.13 (0.02%) |
06-18 16:00 |
|
Open: |
6.38 |
Pre close: |
6.35 |
Target:
|
7.78
|
|
High: |
6.61 |
Low: |
6.38 |
Resistance:
|
6.66
7.08
|
|
Volume: |
141,498 |
Market Cap: |
187M |
Support:
|
5.99
4.98
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.25
 |
MACD |
MACD(12,26):
|
-0.17 |
|
MA(20): |
6.45  |
Signal(12,26,9): |
-0.20 |
|
MA(100): |
7.56 |
Stochastic Oscillator |
%K(14,3):
|
40.31 |
|
MA(250): |
8.40 |
%D(3): |
27.50 |
|
Average Volume(K) |
3-Month: |
17521
|
52-Week |
High:
|
11.37 |
|
10-Days: |
16501 |
Low: |
5.99 |
|
RSI |
RSI(14):
|
48.57 |
Change(%): |
-40.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.130 |
Return on Equity (ttm) |
-66.7 |
Shares Out. (M) |
28.85 |
|
EPS Est. Current Year |
-2.070 |
Return on Assets (ttm) |
-59.9 |
Shares Float (M) |
28.09 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.50 |
|
EPS Est. Next Quarter |
-0.580 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
74.10 |
|
Forward EPS |
-2.600 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.590 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.08 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-40.55 |
P/S |
1869480064.00 |
|
Operating Margin |
-2307.61 |
Levered Free Cash Flow
(M) |
-21.86 |
P/CF |
-4.61 |
|
|
|
|
|
|
